Summary:
The RISE study – Revealing the Impact of Symbicort in reducing Exacerbations in
COPD
Qualified Participants Must:
• Be 40 years of age or older
•
Be a current or previous smoker
•
Have experienced one or more exacerbations of COPD or Chronic Bronchitis requiring treatment with steroids or antibiotics
Qualified Participants May Receive:
Compensation for time and travel (Contact office for more information), Study-related exams, Study-related medications, and Study-related lab work.